TwoStep Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$62.2M
- Investors
-
13
TwoStep Therapeutics General Information
Description
Operator of a biotechnology platform designed to develop tumor-targeting therapeutics for solid tumors. The company offers targeted cancer therapies using an integrin-binding agent to deliver diverse therapeutic payloads to solid tumors, enabling treatment of patients with solid tumor cancers through targeted therapeutic approaches.
Contact Information
Website
www.twosteptx.comCorporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
TwoStep Therapeutics Timeline
TwoStep Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 22-Jul-2026 | $62.2M | Completed | Pre-Clinical Trials | ||
| 4. Accelerator/Incubator | 25-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 24-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 18-Mar-2024 | $6.5M | $6.5M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2024 | Completed | Pre-Clinical Trials |
TwoStep Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TwoStep Therapeutics Patents
TwoStep Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026183433-A1 | Targeted topoisomerase i inhibitor therapy for treating cancer | Pending | 28-Feb-2025 | ||
| WO-2026096948-A1 | Targeted radioligand therapy for treating cancer | Pending | 01-Nov-2024 |
TwoStep Therapeutics Signals
TwoStep Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Insight Partners (New York) | PE/Buyout | Minority | ||
| Medical Excellence Capital | Venture Capital | Minority | ||
| Merck | Corporation | Minority | ||
| M Ventures | Corporate Venture Capital | Minority | ||
| PEAK6 Investments | PE/Buyout | Minority |
TwoStep Therapeutics FAQs
-
When was TwoStep Therapeutics founded?
TwoStep Therapeutics was founded in 2024.
-
Where is TwoStep Therapeutics headquartered?
TwoStep Therapeutics is headquartered in San Carlos, CA.
-
What is the size of TwoStep Therapeutics?
TwoStep Therapeutics has 10 total employees.
-
What industry is TwoStep Therapeutics in?
TwoStep Therapeutics’s primary industry is Biotechnology.
-
Is TwoStep Therapeutics a private or public company?
TwoStep Therapeutics is a Private company.
-
What is the current valuation of TwoStep Therapeutics?
The current valuation of TwoStep Therapeutics is .
-
What is TwoStep Therapeutics’s current revenue?
The current revenue for TwoStep Therapeutics is .
-
How much funding has TwoStep Therapeutics raised over time?
TwoStep Therapeutics has raised $70.9M.
-
Who are TwoStep Therapeutics’s investors?
Insight Partners (New York), Medical Excellence Capital, Merck, M Ventures, and PEAK6 Investments are 5 of 13 investors who have invested in TwoStep Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process